Suzawa, K., Offin, M., Schoenfeld, A. J., Plodkowski, A. J., Odintsov, I., Lu, D., . . . Ladanyi, M. (2019). Acquired MET Exon 14 Alteration Drives Secondary Resistance to Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitor in EGFR-Mutated Lung Cancer. JCO Precis Oncol.
शिकागो स्टाइल उद्धरणSuzawa, Ken, et al. "Acquired MET Exon 14 Alteration Drives Secondary Resistance to Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitor in EGFR-Mutated Lung Cancer." JCO Precis Oncol 2019.
एमएलए उद्धरणSuzawa, Ken, et al. "Acquired MET Exon 14 Alteration Drives Secondary Resistance to Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitor in EGFR-Mutated Lung Cancer." JCO Precis Oncol 2019.
चेतावनी: ये उद्धरण हमेशा 100% सटीक नहीं हो सकते हैं.